Abstract:Trypanosomatids (order Kinetoplastida), including the human pathogens Trypanosoma cruzi (agent of Chagas disease), Trypanosoma brucei, (African sleeping sickness), and Leishmania (leishmaniasis), affect millions of people and animals globally. T. cruzi is considered one of the least studied and most poorly understood tropical disease-causing parasites, in part because of the relative lack of facile genetic engineering tools. This situation has improved recently through the application of clustered regularly interspaced short palindromic repeats-CRISPR-associated protein 9 (CRISPR-Cas9) technology, but a number of limitations remain, including the toxicity of continuous Cas9 expression and the long drug marker selection times. In this study, we show that the delivery of ribonucleoprotein (RNP) complexes composed of recombinant Cas9 from Staphylococcus aureus (SaCas9), but not from the more routinely used Streptococcus pyogenes Cas9 (SpCas9), and in vitro-transcribed single guide RNAs (sgRNAs) results in rapid gene edits in T. cruzi and other kinetoplastids at frequencies approaching 100%. The highly efficient genome editing via SaCas9/sgRNA RNPs was obtained for both reporter and endogenous genes and observed in multiple parasite life cycle stages in various strains of T. cruzi, as well as in T. brucei and Leishmania major. RNP complex delivery was also used to successfully tag proteins at endogenous loci and to assess the biological functions of essential genes. Thus, the use of SaCas9 RNP complexes for gene editing in kinetoplastids provides a simple, rapid, and cloning-and selection-free method to assess gene function in these important human pathogens. IMPORTANCE Protozoan parasites remain some of the highest-impact human and animal pathogens, with very limited treatment and prevention options. The development of improved therapeutics and vaccines depends on a better understanding of the unique biology of these organisms, and understanding their biology, in turn, requires the ability to track and manipulate the products of genes. In this work, we describe new methods that are available to essentially any laboratory and applicable to any parasite isolate for easily and rapidly editing the genomes of kinetoplastid parasites. We demonstrate that these methods provide the means to quickly assess function, including that of the products of essential genes and potential targets of drugs, and to tag gene products at their endogenous loci. This is all achieved without gene cloning or drug selection. We expect this advance to enable investigations, especially in Trypanosoma cruzi and Leishmania spp., that have eluded investigators for decades.

Efficient Gene Disruption in Diverse Strains of <named-content content-type="genus-species">Toxoplasma gondii</named-content> Using CRISPR/CAS9

Efficient Gene Disruption in Diverse Strains of Toxoplasma Gondii Using CRISPR/CAS9.

Using CRISPR / CAS 9 Toxoplasma gondii Efficient Gene Disruption in Diverse Strains of 2014

Efficient Genome Engineering of Toxoplasma gondii Using CRISPR/Cas9

The Past, Present, and Future of Genetic Manipulation in Toxoplasma Gondii

An improved method for introducing site-directed point mutation into the Toxoplasma gondii genome using CRISPR/Cas9

Development of CRISPR/Cas9 for Efficient Genome Editing in Toxoplasma gondii.

A streamlined CRISPR/Cas9 approach for fast genome editing in Toxoplasma gondii and Besnoitia besnoiti

Optimizing Systems for Cas9 Expression in Toxoplasma gondii

Analysis of Noncanonical Calcium-Dependent Protein Kinases in Toxoplasma gondii by Targeted Gene Deletion Using CRISPR/Cas9

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii

Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins

Inducible high-efficiency CRISPR-Cas9-targeted gene editing and precision base editing in African trypanosomes

Knockout of mic3 gene in Toxoplasma gondii using CRISPR/Cas9 technique

Targeted Gene Disruption by CRISPR/xCas9 System in Drosophila Melanogaster.

Toxoplasma CRISPR/Cas9 constructs are functional for gene disruption in Neospora caninum

Evaluation of the basic functions of six calcium-dependent protein kinases in Toxoplasma gondii using CRISPR-Cas9 system

Knockout of leucine aminopeptidase in Toxoplasma gondii using CRISPR/Cas9

An expanded genetic toolkit for inducible expression and targeted gene silencing in

Streptococcus pyogenes Cas9 ribonucleoprotein delivery for efficient, rapid and marker‐free gene editing in Trypanosoma and Leishmania

New and emerging uses of CRISPR/Cas9 to genetically manipulate apicomplexan parasites